Overview Relevant Case Law Under the SPS Agreement

Maggio, Amber Rose

doi:10.1007/978-3-319-61155-6_10

Amber Rose Maggio²⁰

Part of the book series: European Yearbook of International Economic Law ((EYIELMONO,volume 1))

551 Accesses

Abstract

This chapter will now go on to summarise some of the relevant case law under the SPS Agreement. For reasons of space and more limited relevance, it is not possible to summarise these cases to the same extent as in previous chapters. However, the facts will be summarised, as will the most important conclusions of the DSS.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Chapter: USD 29.95; Price excludes VAT (USA)

eBook: USD 79.99; Price excludes VAT (USA)

Softcover Book: USD 99.99; Price excludes VAT (USA)

Hardcover Book: USD 139.99; Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

1.
Panel Report European Communities – Measures Concerning Meat and Meat Products (Hormones) (Canada); Panel Report European Communities – Measures Concerning Meat and Meat Products (Hormones) (US); Award of the Arbitrator, EC – Hormones (Article 21.3(c)); Appellate Body Report EC – Measures Concerning Meat and Meat Products (Hormones) Appellate Body Report Canada – Continued Suspension of Obligations in the EC- Hormones Dispute; Appellate Body Report United States – Continued Suspension of Obligations in the EC- Hormones Dispute.
2.
A parallel Panel was requested by Canada with respect to the same measures. Although were separate, they related to the same EC measures, were dealt with by the same Panel members and were assisted by the same scientific experts. For reasons of space, only the US case will be dealt with in this work.
3.
Panel Report European Communities – Measures Concerning Meat and Meat Products (Hormones) (Canada); Panel Report European Communities – Measures Concerning Meat and Meat Products (Hormones) (US), para. 1.4.
4.
Ibid., para. 2.1
5.
Ibid., para. 2.2.
6.
One where oestrogenic, androgenic or gestagenic substances were used for ‘therapeutic or zootechnical purposes and administered by a veterinarian or under a veterinarian's responsibility’, and another ‘for oestradiol-17, progesterone, testosterone, trenbolone acetate (or TBA) and zeranol – when they were used for growth promotion purposes and their use was governed according to the individual regulatory schemes maintained by EC member States’, ibid.
7.
The Directive extended ‘the prohibition imposed by Directive 81/602/EEC to the administration to farm animals of trenbolone acetate and zeranol for any purpose, and oestradiol-17, testosterone and progesterone for fattening purposes’ while maintaining the exception for zootechnical and therapeutic purposes, ibid., para. 2.3.
8.
Ibid.
9.
Ibid., para. 2.4.
10.
Ibid., para. 2.10.
11.
Ibid., paras. 2.20–2.23.
12.
Ibid., para. 2.26.
13.
Ibid.
14.
For a full account of the European measures and legislation, see ibid., paras. 2.26–2.33.
15.
Ibid., para. 2.34.
16.
Ibid., para. 2.35.
17.
Ibid., para. 3.1.
18.
Ibid., para. 3.2.
19.
Ibid., para. 3.4.
20.
Ibid., para. 3.6.
21.
Ibid.
22.
Ibid.
23.
Ibid.
24.
Ibid., para. 3.8.
25.
Ibid., paras. 6.11 et seq.
26.
Ibid., para. 8.9.
27.
Ibid., paras. 8.21–8.22.
28.
Ibid., para. 8.36.
29.
Ibid., para. 8.39.
30.
Ibid., paras. 8.58 et seq.
31.
Ibid., paras. 8.66–8.67.
32.
Ibid., para. 8.69.
33.
Ibid., para. 8.70.
34.
Ibid., paras. 8.75–8.77.
35.
Ibid., para. 8.89.
36.
Ibid., para. 8.94.
37.
Ibid., para. 8.95.
38.
Ibid., para. 8.97.
39.
Ibid., para. 8.106.
40.
Ibid., para. 8.111.
41.
Ibid., paras. 8.112 et seq.
42.
Ibid., para. 8.112.
43.
Ibid., para. 8.113.
44.
Ibid., paras. 8.114–8.116.
45.
Ibid., para. 8.124.
46.
Ibid., para. 8.134.
47.
Ibid., para. 8.136.
48.
Ibid., para. 8.137.
49.
Ibid., paras. 8.139–8.156.
50.
Ibid., paras. 8.157–8.158.
51.
Ibid., para. 8.161.
52.
Ibid., para. 8.162.
53.
Ibid., para. 8.245.
54.
Appellate Body Report European Communities – Measures Concerning Meat and Meat Products (Hormones), paras. 9–11.
55.
Ibid., paras. 13–14.
56.
Ibid., para. 16.
57.
Ibid., paras. 17–18.
58.
Ibid., paras. 40–71.
59.
Ibid., paras. 72–76.
60.
Ibid., para. 102.
61.
Ibid., para. 115.
62.
Ibid., para. 117.
63.
Ibid., para. 119.
64.
Ibid., para. 123, stating further: ‘We consider, however, that it is unnecessary, and probably imprudent for the Appellate Body in this appeal to take a position on this important, but abstract, question.’
65.
Ibid., para. 124.
66.
Ibid., para. 133.
67.
Ibid.
68.
Ibid., para. 133.
69.
Ibid., para. 143.
70.
Ibid., para. 144.
71.
Ibid., paras. 163–166.
72.
Ibid., para. 172.
73.
Ibid., para. 173.
74.
Ibid., para. 177.
75.
Ibid., para. 180.
76.
Ibid., paras. 181–192.
77.
Ibid., para. 193.
78.
Ibid., para. 194.
79.
Ibid., para. 197.
80.
Ibid., para. 198.
81.
Ibid., paras. 199–200.
82.
Ibid., para. 208.
83.
Ibid., para. 209.
84.
See https://www.wto.org/english/tratop_e/dispu_e/cases_e/ds26_e.htm (last accessed on 05/03/2017).
85.
Panel Report European Communities – Approval and Marketing of Biotech Products.
86.
See https://www.wto.org/english/tratop_e/dispu_e/cases_e/ds291_e.htm (last accessed on 05/03/2017).
87.
Ibid.
88.
Panel Report European Communities – Approval and Marketing of Biotech Products, para. 2.1.
89.
Ibid., para. 2.2.
90.
Ibid., para. 2.4.
91.
Ibid., para. 2.5, ‘More particularly, individual EC member States may provisionally restrict or prohibit the use and/or sale of an approved biotech product in their own territory if these member States have detailed grounds for considering, based on new or additional information or scientific knowledge, that the particular product poses a risk to human health or the environment.’
92.
Ibid., para. 4.10.
93.
Ibid.
94.
Ibid., para. 4.130.
95.
Ibid., para. 4.131.
96.
Ibid., para. 4.132.
97.
Ibid., para. 4.133.
98.
Ibid., para. 4.134.
99.
Ibid., para. 4.332.
100.
Ibid., para. 4.334.
101.
Ibid., para. 4.332.
102.
Ibid.
103.
Ibid., para. 8.3.
104.
Ibid.
105.
Ibid.
106.
Ibid., para. 8.13 (a).
107.
Ibid., para. 8.14 (a).
108.
Ibid., para. 8.14 (b)-(g).
109.
Ibid., para. 8.18 (a).
110.
Ibid., paras. 8.21–8.31.
111.
Ibid., paras. 8.32–8.63.
112.
Art. 8 SPS states: Members shall observe the provisions of Annex C in the operation of control, inspection and approval procedures, including national systems for approving the use of additives or for establishing tolerances for contaminants in foods, beverages or feedstuffs, and otherwise ensure that their procedures are not inconsistent with the provisions of this Agreement. Annex C (1) (a) states: 1. Members shall ensure, with respect to any procedure to check and ensure the fulfilment of sanitary or phytosanitary measures, that: (a) such procedures are undertaken and completed without undue delay and in no less favourable manner for imported products than for like domestic products.

Author information

Authors and Affiliations

Max Planck Foundation for International Peace and the Rule of Law, Heidelberg, Germany
Amber Rose Maggio

Authors

Amber Rose Maggio
View author publications
You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

About this chapter

Cite this chapter

Maggio, A.R. (2017). Overview Relevant Case Law Under the SPS Agreement. In: Environmental Policy, Non-Product Related Process and Production Methods and the Law of the World Trade Organization. European Yearbook of International Economic Law(), vol 1. Springer, Cham. https://doi.org/10.1007/978-3-319-61155-6_10

Download citation

DOI: https://doi.org/10.1007/978-3-319-61155-6_10
Published: 07 October 2017
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61154-9
Online ISBN: 978-3-319-61155-6
eBook Packages: Law and CriminologyLaw and Criminology (R0)

Publish with us

Policies and ethics